# Beta-hCG + Erythropoietin in Acute Stroke

> **NCT00362414** · PHASE2 · COMPLETED · sponsor: **University of California, Irvine** · enrollment: 15 (actual)

## Conditions studied

- Acute Stroke

## Interventions

- **DRUG:** Dual Growth Factor

## Key facts

- **NCT ID:** NCT00362414
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-08-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00362414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00362414, "Beta-hCG + Erythropoietin in Acute Stroke". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00362414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*